Acea Biosciences

IP Roundup

Premium

Yale University, University of South Florida, Alabama State University, Stanford University, SRU Biosystems, Eppendorf Array Technology, Agilent Technologies, Acea Biosciences

The new label-free and real-time cell-based assays will incorporate Vivo's HuBiogel platform.

The firms are developing a system for the early and accurate prediction of cardiotoxic side effects in the drug discovery process.

The US Environmental Protection Agency this week presented for the first time initial data from the first phase of its ToxCast program during the Society of Toxicology's annual meeting, held this year in Baltimore, according to an official from a company who participated in the p

Congress approved a bill Friday that would increase the US National Institutes of Health's funding by $2 billion for fiscal year 2019.

UK's Labour Party calls for a ban on non-invasive prenatal testing for determining sex, BBC News reports.

Sarah Lawrence College's Laura Hercher warns in a New York Times op-ed that more people are going to need help figuring out what their consumer genetic testing results mean.

In PLOS this week: intra-tumor heterogeneity patterns, genomic analysis of Thoroughbred horse origins, and more.